-52.75 (-3.15%) Sun Pharmaceutical Industries has informed that a meeting of the Board of Directors of the Company will be held on November 13, 2014, to consider and take on record the un-audited financial results of the Company for the second quarter ended September 30, 2014 (Q2). Further, window closure for Trading by Designated persons as per insider Trading Rules of the Company will be from October 31, 2014 to November 17, 2014.
The above information is a part of company’s filings submitted to BSE.